shutterstock_273127421 - Clinical Trials Arena
Join Our Newsletter - Get important industry news and analysis sent to your inbox – sign up to our e-Newsletter here
X

UCB to conduct bridging study of UCB0107 in progressive supranuclear palsy this year

shutterstock_273127421
The bridging study will be necessary to provide the safety and pharmacokinetic data needed to advance the anti-tau drug into a Phase III trial planned for 2020.